GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » Gross-Profit-to-Asset %

Ekso Bionics Holdings (LTS:0IFR) Gross-Profit-to-Asset % : 26.77% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ekso Bionics Holdings's annualized Gross Profit for the quarter that ended in Mar. 2025 was $7.22 Mil. Ekso Bionics Holdings's average Total Assets over the quarter that ended in Mar. 2025 was $26.98 Mil. Therefore, Ekso Bionics Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 26.77%.


Ekso Bionics Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Ekso Bionics Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Gross-Profit-to-Asset % Chart

Ekso Bionics Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.85 19.35 13.80 26.01 34.23

Ekso Bionics Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.97 37.71 31.45 38.87 26.77

Competitive Comparison of Ekso Bionics Holdings's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Gross-Profit-to-Asset % falls into.


;
;

Ekso Bionics Holdings Gross-Profit-to-Asset % Calculation

Ekso Bionics Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=9.511/( (28.918+26.652)/ 2 )
=9.511/27.785
=34.23 %

Ekso Bionics Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=7.224/( (26.652+27.31)/ 2 )
=7.224/26.981
=26.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Ekso Bionics Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ekso Bionics Holdings Business Description

Traded in Other Exchanges
Address
101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings Headlines

No Headlines